OGOREK ANTHONY JOSEPH /NY/ /ADV - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 10 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
OGOREK ANTHONY JOSEPH /NY/ /ADV ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$0
-100.0%
3,6000.0%0.00%
Q2 2023$10.0%3,6000.0%0.00%
Q1 2023$1
-66.7%
3,6000.0%0.00%
-100.0%
Q4 2022$3
-99.9%
3,6000.0%0.00%
-50.0%
Q3 2022$5,000
-28.6%
3,6000.0%0.00%
-33.3%
Q2 2022$7,000
-12.5%
3,6000.0%0.00%0.0%
Q1 2022$8,000
-50.0%
3,6000.0%0.00%
-57.1%
Q4 2021$16,000
-40.7%
3,6000.0%0.01%
-41.7%
Q3 2021$27,000
-20.6%
3,6000.0%0.01%
-20.0%
Q2 2021$34,000
+17.2%
3,6000.0%0.02%
+7.1%
Q1 2021$29,000
+20.8%
3,6000.0%0.01%
+7.7%
Q4 2020$24,0003,6000.01%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Oaktree Fund Advisors, LLC 66,000$503,00048.93%
SABBY MANAGEMENT, LLC 1,698,107$12,957,0001.75%
EMFO, LLC 233,008$1,778,0001.57%
swisspartners Ltd. 110,000$839,0000.65%
HERITAGE WEALTH MANAGEMENT, LLC 150,000$1,145,0000.41%
Donald L. Hagan, LLC 42,929$328,0000.19%
COLLECTIVE FAMILY OFFICE LLC 44,203$337,0000.14%
Spectrum Wealth Advisory Group, LLC 18,093$138,0000.14%
NEXPOINT ASSET MANAGEMENT, L.P. 100,000$763,0000.13%
Cormorant Asset Management, LP 400,000$3,052,0000.12%
View complete list of SORRENTO THERAPEUTICS INC shareholders